Kathleen J. Yost

Socioeconomic status and breast cancer incidence in California for different race/ethnic groups

Kathleen J. Yost, Carin Perkins, Richard. D. Cohen et al. · Cancer Causes & Control · 2001 · 949 citations

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel, Megan Othus, Yuanbin Chen et al. · New England Journal of Medicine · 2023 · 741 citations · Full text

Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients

Kathleen J. Yost, David T. Eton, Sofia F. Garcia et al. · Journal of Clinical Epidemiology · 2011 · 589 citations

Surgical Oncology, Health Informatics, Important Differences +12

General Population and Cancer Patient Norms for the Functional Assessment of Cancer Therapy-General (FACT-G)

Penny S. Brucker, Kathleen J. Yost, John Cashy et al. · Evaluation & the Health Professions · 2005 · 522 citations

Quality Of Life, Life Assessment, Cancer Management +18

A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale

David T. Eton, David Cella, Kathleen J. Yost et al. · Journal of Clinical Epidemiology · 2004 · 375 citations

Surgical Oncology, Important Differences, Breast Oncology +14